02

Selected for the KDDF Regulatory Affairs (RA) Support Program under the National New Drug Development Project

11

Selected for the Scale-up TIPS Program for High-Growth Startups (Ministry of SMEs and Startups)

11

Selected for the Academia-Industry Collaborative New Drug Development Support Program

07

Selected for JLABS Korea

02

Registered Russian patent (anti-cancer agent targeting cancer stemness)

12

Selected for the SME Overseas Marketing Support Program by the Ministry of SMEs and Startups

12

Chosen as one of the Top 10 Outstanding Projects among 347 projects in the National New Drug Development Project(KDDF)

11

Bronze Prize at the KIT Technology Commercialization and Investment Promotion Competition

11

Registered Australian patent (anti-cancer agent targeting cancer stemness)

08

Registered domestic patent

06

Selected for the Market Expansion-Type Support Program under the SME Technology Innovation Development Project

03

Selected for the Lead Compound Support Program under the National New Drug Development Project

11

Selected for the Non-clinical Support Program under the National New Drug Development Project(KDDF)

03

Relocated to Seoul National University Bundang Hospital Healthcare Innovation Park

01

Filed PCT patent (related to anti-cancer agent targeting cancer stemness)

12

Certified as an INNO-BIZ (Innovative SME) company

09

Selected as a TIPS-recommended startup team

07

Selected for the BIG3 Innovation Sector Support Program

04

Selected for Infectious Disease Prevention and Treatment Technology Development Project (Ministry of Health and Welfare)

04

Selected for One-Stop Support Program for Future Medical Industry at Advanced Medical Complex

01

Filed domestic patent (related to anti-cancer agent targeting cancer stemness)

10

VC funding

11

Certified as a venture company

05

Registered exclusive license for patent implementation

12

Relocated to Institut Pasteur Korea

11

Selected for Bio Core Facility Construction Project

04

Established an in-house corporate research institute

03

Company founded